Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
A new oral GLP-1 receptor agonist, aleniglipron, has shown 11.3% average body-weight loss in a Phase 2b trial of 230 adults with overweight or obesity after 36 weeks, according to ... Read More
Continuous Coverage
Nigerian gospel music icon Tope Alabi has brought a wave of spiritual fervor to Columbus, Ohio, as her…
Microsoft Teams’ message export feature, now rolling out in this week’s beta, redefines enterprise data governance with granular…
Is Ozempic Linked to Ariana Grande’s Weight Loss? A Plastic Surgeon’s Clinical Analysis Recent speculation about Ariana Grande’s…
Dua Lipa and Callum Turner exchanged vows in a lavish Palermo ceremony, culminating in a 10-minute firework display,…
New Zealand rugby franchises have secured all four semifinal berths in the 2026 DHL Super Rugby Pacific playoffs,…
Gears of War: E-Day was set for a PlayStation 5 launch this summer, but Xbox abruptly cancelled its…
Global Affairs
Hungary’s government has tightened restrictions on non-EU foreign workers, signaling a broader shift in its migration policy. The…
Markets And Money
Saber Interactive, a subsidiary of Beacon Interactive, has announced the upcoming release of the Hitman Classic Trilogy, a…
Digital Culture
The Xiaomi Redmi Note 15 Pro+ has officially breached the sub-€300 price floor on Cdiscount as of June…
Science And Wellbeing
Cystic fibrosis (CF) carrier screening programs frequently utilize panels designed for individuals of European descent, inadvertently creating diagnostic…
Screen And Sound
Take That’s final flight from Coventry Airport on June 6 marked the end of their Circus Live tour—a…
Fixtures And Form
Dirk Kuyt, ranked 81st in the official Liverpool FC “Greatest” list, remains a definitive archetype of the Rafa…
